US equities |
MU $924.72 ▲+5.22% NVDA $219.18 ▲+2.36% TSLA $367.91 ▲+3.72% SNDK $1,399.50 ▲+7.71% AMZN $263.07 ▲+5.23% SPCX $150.03 ▲+2.74% AMD $552.16 ▲+4.43% META $703.13 ▼-0.87%
FinancialContent

Latest News about Michael Mullette

Recent news which mentions Michael Mullette

Shake Up At Lykos Therapeutics After FDA Blocks Ecstasy-Based Treatment, CEO Steps Down
Tickers CMPS NEWS
Tags Multidisciplinary Association for Psychedelic Studies (MAPS) Michael Mullette CMPS
From Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
Tickers AWKNF
Tags MDMA/assisted therapy Exclusives Benzinga Psychedelics Capital Conference
From Benzinga
Former Moderna Vice President Joins Psychedelics Company In Phase 3 Trials For Ecstasy
Tickers MAPS
Tags Cannabis Benzinga Michael Mullette
From Benzinga